AIM · Insider Trading
AIM ImmunoTech Inc.
Every open-market purchase and sale reported by AIM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Thomas K Equels | CEO & President | Buy | +31,675 | +$5.07K |
| 2026-10-23 | Thomas K Equels | CEO & President | Buy | +31,250 | +$5.09K |
| 2026-09-18 | Thomas K Equels | CEO & President | Buy | +24,000 | +$4.99K |
| 2026-09-17 | Thomas K Equels | CEO & President | Buy | +11,000 | +$2.31K |
| 2026-09-16 | Thomas K Equels | CEO & President | Buy | +22,000 | +$4.86K |
| 2026-09-15 | Thomas K Equels | CEO & President | Buy | +5,900 | +$1.29K |
| 2026-03-16 | David I. Chemerow | Director | C | +25,000 | — |
| 2026-03-16 | Thomas K Equels | CEO & President | C | +25,000 | — |
| 2026-03-10 | David I. Chemerow | Director | J | — | — |
| 2026-03-10 | Thomas K Equels | CEO & President | J | — | — |
| 2026-02-06 | David I. Chemerow | Director | A | +2,800 | +$3.44K |
| 2025-07-21 | Ted D Kellner | Director | — | — | — |
| 2025-06-16 | Thomas K Equels | CEO & President | Buy | +107 | +$824 |
| 2025-06-13 | Thomas K Equels | CEO & President | Buy | +103 | +$896 |
| 2025-04-23 | Ted D Kellner | Director | Buy | +1,968,504 | +$50.00K |
| 2025-04-23 | William M Mitchell | Director | Buy | +196,851 | +$5.00K |
| 2025-04-23 | Thomas K Equels | CEO & President | Buy | +1,968,504 | +$50.00K |
| 2025-04-07 | Thomas K Equels | CEO & President | Buy | +41,000 | +$2.58K |
| 2025-04-04 | Peter W Rodino III | COO, Secretary, Gen. Counsel | Buy | +500 | +$44 |
| 2025-03-18 | Nancy Bryan | Director | A | +44,899 | +$5.21K |
| 2025-03-18 | David I. Chemerow | Director | A | +44,899 | +$5.21K |
| 2025-03-18 | William M Mitchell | Director | A | +44,899 | +$5.21K |
| 2025-03-06 | Thomas K Equels | CEO & President | Buy | +50,000 | +$6.73K |
| 2025-03-05 | Thomas K Equels | CEO & President | Buy | +44,000 | +$5.06K |
| 2025-03-04 | Nancy Bryan | Director | A | +38,580 | +$5.21K |
| 2025-03-04 | Thomas K Equels | CEO & President | Buy | +83,334 | +$10.00K |
| 2025-03-04 | William M Mitchell | Director | A | +38,580 | +$5.21K |
| 2025-03-04 | David I. Chemerow | Director | A | +19,290 | +$2.60K |
| 2025-02-20 | William M Mitchell | Director | A | +25,797 | +$5.21K |
| 2025-02-20 | William M Mitchell | Director | A | +43,330 | +$5.21K |
| 2025-02-20 | William M Mitchell | Director | A | +27,412 | +$5.21K |
| 2025-02-19 | Nancy Bryan | Director | A | +43,330 | +$5.21K |
| 2025-02-19 | William M Mitchell | Director | A | −43,330 | −$5.21K |
| 2025-02-03 | William M Mitchell | Director | A | −25,797 | −$5.21K |
| 2025-02-03 | Nancy Bryan | Director | A | +25,797 | +$5.21K |
| 2025-01-21 | Thomas K Equels | CEO & President | Buy | +20,000 | +$4.24K |
| 2025-01-17 | Nancy Bryan | Director | A | +27,412 | +$5.21K |
| 2025-01-17 | William M Mitchell | Director | A | −27,412 | −$5.21K |
| 2025-01-03 | Stewart Appelrouth | Director | A | +8,768 | +$1.74K |
| 2025-01-03 | Nancy Bryan | Director | A | +26,305 | +$5.21K |
| 2025-01-03 | William M Mitchell | Director | A | +26,305 | +$5.21K |
| 2024-12-20 | William M Mitchell | Director | Sell | −4,580 | −$884 |
| 2024-12-19 | Thomas K Equels | CEO & President | Buy | +22,727 | +$4.68K |
| 2024-12-17 | William M Mitchell | Director | A | +24,452 | +$5.21K |
| 2024-12-17 | Stewart Appelrouth | Director | A | +24,452 | +$5.21K |
| 2024-12-17 | Nancy Bryan | Director | A | +24,452 | +$5.21K |
| 2024-12-04 | Stewart Appelrouth | Director | Buy | +11,112 | +$2.36K |
| 2024-12-03 | William M Mitchell | Director | A | +22,645 | +$5.21K |
| 2024-12-03 | Nancy Bryan | Director | A | +22,645 | +$5.21K |
| 2024-12-03 | Stewart Appelrouth | Director | A | +22,645 | +$5.21K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Ted D Kellner | Director | 2,005,763 | $328.54K |
| William M Mitchell | Director | 522,435 | $85.57K |
| Peter W Rodino III | COO, Secretary, Gen. Counsel | 402,164 | $65.87K |
| Stewart Appelrouth | Director | 389,118 | $63.74K |
| Nancy Bryan | Director | 292,174 | $47.86K |
| Thomas K Equels | CEO & President | 158,072 | $25.89K |
| David I. Chemerow | Director | 31,882 | $5.22K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AIM quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.